NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI

被引：6
|
作者：
Facchinetti, Francesco [1 ]
Tiseo, Marcello [1 ]
Gnetti, Letizia [2 ]
Silini, Enrico Maria [2 ]
Ardizzoni, Andrea [1 ]
机构：
[1] Univ Hosp Parma, Med Oncol Unit, I-43100 Parma, Italy
[2] Univ Hosp Parma, Surg Pathol Unit, I-43100 Parma, Italy
来源：
LUNG CANCER | 2013年 / 82卷 / 01期
关键词：
CARCINOMA;
D O I：
10.1016/j.lungcan.2013.07.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：177 / 178
页数：2
相关论文
共 50 条
  • [41] Efficacy of Radiotherapy Combined with EGFR-TKI in the Treatment of EGFR/TP53 Co-Mutated NSCLC
    Zeng, S.
    Wang, L. L.
    Tao, D.
    Zhou, W.
    Wu, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E86 - E86
  • [42] Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma
    Tseng, Jeng-Sen
    Yang, Tsung-Ying
    Tsai, Chi-Ren
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Tsai, Meen-Hsin
    Yu, Sung-Liang
    Su, Kang-Yi
    Chen, Jeremy J. W.
    Chang, Gee-Chen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (04) : 603 - 610
  • [43] NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment
    Koba, Hayato
    Kimura, Hideharu
    Yoneda, Taro
    Ogawa, Naohiko
    Tanimura, Kota
    Tambo, Yuichi
    Sone, Takashi
    Hosomichi, Kazuyoshi
    Tajima, Atsushi
    Kasahara, Kazuo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (11) : 4161 - +
  • [44] Monitoring of carcinoembryonic antigen levels is predictive of EGFR mutations and efficacy of EGFR-TKI in patients with lung adenocarcinoma
    Zhang, Yanwei
    Jin, Bo
    Shao, Minhua
    Dong, Yu
    Lou, Yuqing
    Huang, Aimi
    Han, Baohui
    TUMOR BIOLOGY, 2014, 35 (05) : 4921 - 4928
  • [45] EGFR-TKI Alone or with Concomitant Radiotherapy for Brain Metastases in Lung Adenocarcinoma Patients with EGFR Gene Mutations
    Chen, Yongshun
    Yang, Jing
    Li, Xue
    Hao, Daxuan
    Wu, Xiaoyuan
    Yang, Yuanyuan
    Hu, Xiaona
    He, Chunyu
    Wang, Wen
    Liu, Jinsong
    Wang, Jianhua
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S278 - S278
  • [46] Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S980 - S981
  • [47] Interaction between miR-1 and tumor immune microenvironment in EGFR-TKI resistant lung adenocarcinoma
    Kawana, Sachiko
    Saito, Ryoko
    Miki, Yasuhiro
    Kimura, Yuichiro
    Abe, Jiro
    Sato, Ikuro
    Sugawara, Shunichi
    Sasano, Hironobu
    CANCER SCIENCE, 2021, 112 : 815 - 815
  • [48] EGFR-TKI Plus Brain Radiotherapy Versus EGFR-TKI Alone in the Management of EGFR Mutated NSCLC Patients with Brain Metastases: A Meta-Analysis
    Xia, X.
    Guo, M.
    He, J.
    Liang, W.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S382 - S382
  • [49] Efficacy and safety of original EGFR-TKI combined with bevacizumab in advanced lung adenocarcinoma patients harboring EGFR-mutation experiencing gradual progression after EGFR-TKI treatment: a single-arm study
    Long, Jianlin
    Lei, Shuangyi
    Wu, Zhijuan
    Xiong, Shuanglong
    Wang, Chunmei
    Huang, Lumi
    Liang, Guanzhong
    Yang, Dan
    Teng, Yan
    Li, Yongsheng
    Qi, Jun
    Li, Dairong
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (24)
  • [50] Low-dose anlotinib combined with EGFR-TKI can be used as an alternative for EGFR-TKI-resistant non-small cell lung cancer in elderly patients
    Chen, Yi
    Jiang, Nanyuan
    Liang, Xiao
    Chen, Nan
    Chen, Yun
    Zhang, Chen
    Shi, Junfeng
    Guo, Renhua
    ONCOLOGY LETTERS, 2023, 26 (02)
12345